Arnold Degboe

866 total citations
31 papers, 600 citations indexed

About

Arnold Degboe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Arnold Degboe has authored 31 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Arnold Degboe's work include PARP inhibition in cancer therapy (12 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). Arnold Degboe is often cited by papers focused on PARP inhibition in cancer therapy (12 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Breast Cancer Therapies (7 papers). Arnold Degboe collaborates with scholars based in United States, United Kingdom and Japan. Arnold Degboe's co-authors include Rhonda BeLue, Titilayo A. Okoror, Gbenga Ogedegbe, Juliet Iwelunmor, Kelly Taylor, Charles Agyemang, Anthony Q. Q. Aboagye, Jeffrey M. Rohay, Ralph R. Turner and David Cella and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Arnold Degboe

31 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold Degboe United States 11 136 102 101 88 84 31 600
Siméon-Pierre Choukem Cameroon 14 37 0.3× 95 0.9× 63 0.6× 27 0.3× 65 0.8× 41 514
Henry Ko Australia 10 62 0.5× 190 1.9× 54 0.5× 10 0.1× 50 0.6× 15 661
David E. Milov United States 12 53 0.4× 89 0.9× 50 0.5× 17 0.2× 35 0.4× 27 660
Margaret Nolan United States 14 55 0.4× 97 1.0× 32 0.3× 16 0.2× 72 0.9× 39 729
Sébastien Lamy France 13 111 0.8× 95 0.9× 52 0.5× 12 0.1× 32 0.4× 60 507
Kevin P. Shah United States 10 184 1.4× 129 1.3× 60 0.6× 58 0.7× 9 0.1× 26 517
Aleksei Baburin Estonia 13 142 1.0× 56 0.5× 55 0.5× 6 0.1× 76 0.9× 49 498
Ike Iheanacho United Kingdom 12 67 0.5× 58 0.6× 239 2.4× 14 0.2× 47 0.6× 36 734
Julia Roscoe Canada 10 51 0.4× 79 0.8× 47 0.5× 72 0.8× 10 0.1× 18 467
Hyun Kyung Kim South Korea 16 34 0.3× 117 1.1× 62 0.6× 26 0.3× 53 0.6× 54 662

Countries citing papers authored by Arnold Degboe

Since Specialization
Citations

This map shows the geographic impact of Arnold Degboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Degboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Degboe more than expected).

Fields of papers citing papers by Arnold Degboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Degboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Degboe. The network helps show where Arnold Degboe may publish in the future.

Co-authorship network of co-authors of Arnold Degboe

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Degboe. A scholar is included among the top collaborators of Arnold Degboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Degboe. Arnold Degboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saad, Fred, Andrew J. Armstrong, Karina Vianna, et al.. (2024). Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial. European Urology Oncology. 7(6). 1394–1402. 7 indexed citations
2.
3.
Saad, Fred, Antoine Thiery-Vuillemin, Paweł Wiechno, et al.. (2022). Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial. The Lancet Oncology. 23(10). 1297–1307. 21 indexed citations
4.
Coles, Theresa, Adrian F. Hernandez, Bryce B. Reeve, et al.. (2021). Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials. Health and Quality of Life Outcomes. 19(1). 164–164. 10 indexed citations
5.
Robson, Mark E., Kathryn J. Ruddy, Seock‐Ah Im, et al.. (2019). Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. European Journal of Cancer. 120. 20–30. 57 indexed citations
6.
Herman, Joseph M., Helen Kitchen, Arnold Degboe, et al.. (2019). Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment. Quality of Life Research. 28(11). 2929–2939. 12 indexed citations
7.
Degboe, Arnold, Cristina Ivanescu, Jeffrey M. Rohay, Ralph R. Turner, & David Cella. (2019). Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients. Supportive Care in Cancer. 27(11). 4189–4198. 31 indexed citations
8.
Degboe, Arnold, S.L. Knight, Katarina Halling, et al.. (2018). Patients’ experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study. Journal of Patient-Reported Outcomes. 2(1). 33–33. 10 indexed citations
9.
10.
Robertson, J.F.R., Kwok‐Leung Cheung, Shinzaburo Noguchi, et al.. (2018). Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer. European Journal of Cancer. 94. 206–215. 14 indexed citations
11.
12.
13.
Rodríguez, David, Ariane K. Kawata, Arnold Degboe, et al.. (2015). Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities. Clinical Cosmetic and Investigational Dermatology. 8. 231–231. 8 indexed citations
14.
Daniels, Selena, et al.. (2015). Acne-Related Quality of Life Among Female Adults of Different Races/Ethnicities. Journal of the Dermatology Nurses’ Association. 7(3). 154–162. 27 indexed citations
15.
Costa, P., Daisy Ng‐Mak, Arun Sahai, et al.. (2014). Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder. Current Medical Research and Opinion. 30(8). 1557–1564. 10 indexed citations
16.
Degboe, Arnold, Paul Super, J. E. M. Robinson, et al.. (2013). Safety and Effectiveness of LAP-BAND AP System: Results of Helping Evaluate Reduction in Obesity (HERO) Prospective Registry Study at 1 Year. Journal of the American College of Surgeons. 217(5). 907–918. 6 indexed citations
17.
Degboe, Arnold, Rhonda BeLue, & Marianne M. Hillemeier. (2011). Parental immigrant status and adolescent mental health in the United States: do racial/ethnic differences exist?. Child and Adolescent Mental Health. 17(4). 209–215. 8 indexed citations
18.
Aboagye, Anthony Q. Q., et al.. (2011). Estimating the cost of healthcare delivery in three hospitals in southern Ghana. Ghana Medical Journal. 44(3). 83–92. 19 indexed citations
19.
Aboagye, Anthony Q. Q. & Arnold Degboe. (2010). Cost analysis and efficiency of sub‐district health facilities in two districts in Ghana. The International Journal of Health Planning and Management. 26(2). 173–190. 5 indexed citations
20.
BeLue, Rhonda, Titilayo A. Okoror, Juliet Iwelunmor, et al.. (2009). An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and Health. 5(1). 10–10. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siméon-Pierre Choukem Breakdown of academic impact, for papers by Henry Ko Breakdown of academic impact, for papers by David E. Milov Breakdown of academic impact, for papers by Margaret Nolan Breakdown of academic impact, for papers by Sébastien Lamy Breakdown of academic impact, for papers by Kevin P. Shah Breakdown of academic impact, for papers by Aleksei Baburin Breakdown of academic impact, for papers by Ike Iheanacho Breakdown of academic impact, for papers by Julia Roscoe Breakdown of academic impact, for papers by Hyun Kyung Kim
Rankless by CCL
2026